RTK Group is a family office backed biopharmaceutical advisory and investment fund focused on emerging technologies having disruptive impact and significant potential to benefit patients.
We focus our efforts where we can leverage our unique expertise in company formation and technology development to assist high‐performing management teams realize the full value potential of their technology.
Committed to Making Game-Changing Healthcare Contributions
Team of experienced life‐science professionals with experience across all sectors of health care
Long-Term Investor With Innovative Solutions
Improving the World – One Investment at a Time
We embrace scientific risk and support research with high impact potential. Our belief is that investing in promising concepts backed by solid science creates the potential for significant value creation.
High performing teams are critical to allow promising technologies to realize their full potential. We back innovators at all stages of their entrepreneurial career and support teams as needed with our expertise in company formation and technology development.
Our ultimate goal is to improve the human condition through our support of technology development. Leaving the potential for a better future for our future generations is what motivates us to foster scientific innovation and teams dedicated to improving patient lives.
RTK is a biopharmaceutical advisory and investment fund that supports companies
by enabling them to develop promising technologies and reach their potential to benefit patients.
We have one goal: to enable better patient lives and a better world through better healthcare. We take great satisfaction in partnering with companies having high potential to disrupt the healthcare ecosystem and helping support high‐performing management teams to realize their goals.